Our Products

Erlotinib Tablets 100 mg is a targeted therapy medication used primarily for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It is an epidermal growth factor receptor (EGFR) inhibitor that works by blocking the activity of the EGFR, a protein involved in the growth and spread of cancer cells. By inhibiting EGFR, Erlotinib helps slow the growth of cancer cells that depend on this receptor for survival and proliferation.

The 100 mg dosage is typically taken once daily, with or without food, as prescribed by a healthcare provider. Common side effects may include skin rash, diarrhea, nausea, loss of appetite, fatigue, and liver enzyme abnormalities. Regular monitoring of liver function and skin health is recommended during treatment to manage potential side effects and ensure the medication’s effectivenErlotinib Tablets 150 mg is a targeted therapy medication used primarily for the treatment of non-small cell lung cancer (NSCLC) and pancreatic cancer. It works as an epidermal growth factor receptor (EGFR) inhibitor by blocking the activity of the EGFR, a protein that helps regulate cell growth. By inhibiting EGFR, Erlotinib can slow or stop the growth of cancer cells that rely on this receptor for their proliferation.

The typical dosage of 150 mg is usually taken once daily, with or without food, as prescribed by a healthcare provider. Common side effects include skin rash, diarrhea, nausea, loss of appetite, fatigue, and liver enzyme changes. Regular monitoring of liver function, as well as managing skin reactions and gastrointestinal issues, is important during treatment to ensure the medication’s effectiveness and minimize potential side effects.